PART II Item 5. MARKET FOR THE REGISTRANT’S COMMON STOCK AND OTHER STOCKHOLDER MATTERS. Holders of Common Stock Equity Compensation Plan Information Performance Graph Bristol-Myers Squibb common stock is traded on the New York Stock Exchange (Symbol: BMY). The number of record holders of our common stock at January 31, 2021 was 36,187. The number of record holders is based upon the actual number of holders registered on our books at such date based on information provided by EQ Shareowner Services, our transfer agent, and does not include holders of shares in “street names” or persons, partnerships, associations, corporations or other entities identified in security position listings maintained by depository trust companies. Information required by this item will be contained in our 2021 Proxy Statement under the heading “Items to be Voted Upon—Item 2—Advisory Vote to Approve the Compensation of our Named Executive Officers-Equity Compensation Plan Information,” which information is incorporated herein by reference. The following graph compares the cumulative total stockholders’ returns of our common shares with the cumulative total stockholders’ returns of the companies listed in the Standard & Poor’s 500 Index and a composite peer group of major pharmaceutical companies comprised of AbbVie, Amgen, AstraZeneca, Biogen, Gilead, GlaxoSmithKline, Johnson & Johnson, Lilly, Merck, Novartis, Pfizer, Roche and Sanofi. The graph assumes $100 investment on December 31, 2015 in each of our common shares, the S&P 500 Index and the stock of our peer group companies, including reinvestment of dividends, for the years ended December 31, 2016, 2017, 2018, 2019 and 2020. The stock price performance on the following graph is not necessarily indicative of future stock price performance. 35 2015 2016 2017 2018 2019 2020 Bristol-Myers Squibb $ 100.00  $ 86.51  $ 93.18  $ 81.16  $ 103.67  $ 104.10  S&P 500 100.00  111.96  136.40  130.42  171.49  203.04  Peer Group 100.00  99.45  114.61  126.10  147.87  150.86 